Actinium-225 Production with an Electron Accelerator
W. T. Diamond, C. K. Ross

TL;DR
This paper discusses a novel method for producing Ac-225, a crucial isotope for targeted alpha therapy, using an electron accelerator with detailed technical design and yield modeling to enhance availability for medical applications.
Contribution
It introduces a new accelerator-based production method for Ac-225 using photonuclear reactions with radium targets, including detailed target design and yield optimization.
Findings
Potential to produce nearly four curies of Ac-225 in 10 days
Design of radium targets capable of multiple extractions
Monte Carlo modeling supports yield estimates and isotope purity
Abstract
There has been growing clinical evidence of the value of targeted alpha therapy for treatment of several cancers. The work has been slowed by the lack of availability of the key alpha emitting isotopes, especially Ac-225. Until this time, most of the supply has been from three Th-229 generators that are milked to produce hundreds of mCi of Ac-225 every month. There has been a growing effort to produce new sources of Ac-225 from several different accelerator-based routes. It can be produced with medical-isotope cyclotrons with a proton energy of at least 16 MeV using the reaction Ra-226(p,2n)Ac-225. It can also be produced by using high-energy protons (150 to 800 MeV) for spallation of a thorium target. Significant experimental work has been applied to both processes. It can also be produced by the photonuclear reaction, Ra-226({\gamma},n)Ra-225. The Ra-225 decays via beta decay to…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
